Physician profile
Kenneth Williams
NPI 1740285329
$25,614.88
in general payments reported to CMS, 2019-2025
14 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.07 · 2020: $96.91 · 2021: $583 · 2022: $2,823 · 2023: $572 · 2024: $21K · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $21K · Food and Beverage: $708 · Travel and Lodging: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $21,000.00 |
| Food and Beverage | $707.81 |
| Travel and Lodging | $316.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $21,068.43 | 2023-2024 | |
| Triad Life Sciences INC. | $2,689.47 | 2022 | |
| Treace Medical Concepts, INC. | $981.67 | 2021-2023 | |
| Smith+Nephew, INC. | $353.80 | 2020-2025 | Collagenase Santyl, Regranex |
| Stryker Corporation | $219.09 | 2019-2025 | Prostep Mica |
| Orthofix Medical, INC. | $101.03 | 2019-2025 | Physio-Stim |
| Medline Industries LP | $47.88 | 2020-2022 | |
| Integra Lifesciences Corporation | $35.83 | 2019 | |
| Atland Pharmaceuticals, LLC | $25.72 | 2024 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Nvision Biomedical Technologies, INC. | $24.10 | 2022 | |
| Kerecis Limited | $24.06 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paragon 28, INC. | $21.96 | 2022 | |
| Arteriocyte Medical Systems, INC. | $11.02 | 2023 | Magellan |
| Cashflow Solutions, LLC | $10.82 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.